ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,427, issued on April 21, was assigned to RED MOUNTAIN MED SPA LLC (Scottsdale, Ariz.).
"Sublingual semaglutide-BPC 157 combination for weight loss" was invented by Suzanne Bentz (Scottsdale, Ariz.), Austin Lucht (Scottsdale, Ariz.) and Shelly Kocher (Scottsdale, Ariz.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Sublingual Semaglutide compositions may comprise both Semaglutide or a salt thereof and a gastric peptide or salt thereof, in combination. The use of a gastric peptide mitigates gastrointestinal side effects of Semaglutide. A weight loss regimen comprises administration of sublingual Semaglutide compositions in the physical form of sublin...